BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6088338)

  • 21. Comparative evaluation of netilmicin-ticarcillin and tobramycin-ticarcillin in the treatment of serious systemic infections in elderly patients.
    Jansen W; Schwarz A
    Clin Ther; 1984; 7(1):112-20. PubMed ID: 6394127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experience with the third generation cephalosporins, cefoperazone and cefotaxime: report.
    Reddy J
    N Z Med J; 1984 May; 97(755):293-6. PubMed ID: 6328390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective randomized trial of ceftazidime versus netilmicin plus mezlocillin in the empirical therapy of presumed sepsis in cirrhotic patients.
    McCormick PA; Greenslade L; Kibbler CC; Chin JK; Burroughs AK; McIntyre N
    Hepatology; 1997 Apr; 25(4):833-6. PubMed ID: 9096584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Netilmicin: chemical development and overview of clinical research.
    Herting RL; Lane AZ; Lorber RR; Wright JJ
    Scand J Infect Dis Suppl; 1980; Suppl 23():20-9. PubMed ID: 7010547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Netilmicin and netilmicin-rifampicin combination in targeted treatment of staphylococcal infections].
    Andreoni M; Picchini G; Ricciardiello P
    Clin Ter; 1986 Sep; 118(5):333-8. PubMed ID: 3757469
    [No Abstract]   [Full Text] [Related]  

  • 26. The treatment of gynaecological and intra-abdominal infections: a comparative study of cefotetan versus netilmicin plus clindamycin.
    Poularas J; Giamarellou H; Vlachos G; Theakou R; Patoulis J; Lekakos N; Stavridis J; Sfikakis P
    J Chemother; 1989 Jul; 1(4 Suppl):880-1. PubMed ID: 16312684
    [No Abstract]   [Full Text] [Related]  

  • 27. Outcome of peritonitis treated with intraperitoneal (i.p.) weekly vancomycin and i.p. daily netilmicin.
    Chadwick DH; Agarwal S; Vora BJ; Hair M; McKewan A; Gokal R
    J Nephrol; 1999; 12(5):318-21. PubMed ID: 10630696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized study of ceftazidime versus gentamicin plus cefotaxime for infections in severe granulocytopenic patients.
    de Pauw BE; Kauw F; Muytjens H; Williams KJ; Bothof T
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():93-9. PubMed ID: 6311790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Netilmicin in the treatment of gram-negative bacillary infections.
    Messihi J; Smith LG; Najjar S
    J Med Soc N J; 1983 Mar; 80(3):193-6. PubMed ID: 6575181
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical evaluation of cefotaxime versus gentamicin plus clindamycin in the treatment of polymicrobial peritonitis.
    Stone HH; Geheber CE; Kolb LD; Strom PR
    Clin Ther; 1982; 5 Suppl A():1-9. PubMed ID: 6293712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Moxalactam versus gentamicin-clindamycin in surgical sepsis. Efficacy and safety.
    Stone HH; Kolb L; Geheber CE
    Schweiz Rundsch Med Prax; 1983 Mar; 72(11):351-5. PubMed ID: 6221242
    [No Abstract]   [Full Text] [Related]  

  • 32. [A series of clinical study on netilmicin].
    Ji S; Wang R; Wang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 Jun; 22(6):354-7. PubMed ID: 11775826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of netilmicin in life threatening sepsis.
    Atukorala SD; Ranganathan S; Muthukumarana HT
    Ceylon Med J; 1984 Mar; 29(1):43-6. PubMed ID: 6525643
    [No Abstract]   [Full Text] [Related]  

  • 34. A randomized controlled clinical trial on etimicin, a new aminoglycoside antibiotic, versus netilmicin in the treatment of bacterial infections.
    Zhao C; Li J; Hou J; Guo M; Zhang Y; Chen Y
    Chin Med J (Engl); 2000 Nov; 113(11):1026-30. PubMed ID: 11776118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical studies on netilmicin (author's transl)].
    Tokunaga K; Fukuda Y; Ando M; Tokuomi H; Yamada H; Kohzuma K; Nakashima H
    Jpn J Antibiot; 1982 Feb; 35(2):675-81. PubMed ID: 7087186
    [No Abstract]   [Full Text] [Related]  

  • 36. Netilmicin 150 mg every 12 hours in systemic infections.
    Haverkorn MJ
    J Antimicrob Chemother; 1983 Sep; 12(3):209-17. PubMed ID: 6630105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical efficacy of cefotaxime in two different periods.
    Peralta S; Vitale B; Scarsi C; D'Aiello G; Rotondo G; Delle Vedove G; Rini GB
    J Chemother; 1989 Jul; 1(4 Suppl):648-9. PubMed ID: 16312574
    [No Abstract]   [Full Text] [Related]  

  • 38. A prospective randomised comparison of cefotaxime vs. netilmicin vs. cefotaxime plus netilmicin in the treatment of hospitalised patients with serious sepsis.
    Sage R; Nazareth B; Noone P
    Scand J Infect Dis; 1987; 19(3):331-7. PubMed ID: 3616496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ceftriaxone versus combined gentamicin and clindamycin for polymicrobial surgical sepsis.
    Stone HH; Mullins RJ; Strom PR; Bourneuf AA; Geheber CE
    Am J Surg; 1984 Oct; 148(4A):30-4. PubMed ID: 6091478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Netilmicin in moderate to severe infections in newborns and infants: a study of efficacy, tolerance and pharmacokinetics.
    Henriksson P; Svenningsen NW; Juhlin I; Haeger K
    Scand J Infect Dis Suppl; 1980; Suppl 23():155-9. PubMed ID: 7010546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.